Using genetic information to predict breast cancer risk
Prediction of interval breast cancer risk using genetic variants
['FUNDING_CAREER'] · WEILL MEDICAL COLL OF CORNELL UNIV · NIH-10669796
This study is looking at how your genes might help predict the risk of developing breast cancer between regular check-ups, so that we can create better screening methods tailored just for you, leading to earlier detection and improved outcomes.
Quick facts
| Phase | ['FUNDING_CAREER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WEILL MEDICAL COLL OF CORNELL UNIV (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-10669796 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding how genetic variants can help predict the risk of developing interval breast cancer, which occurs between regular screening tests. The project aims to enhance cancer screening and prevention strategies by analyzing tumor gene expression and developing predictive models. Patients may benefit from personalized screening approaches based on their genetic profiles, potentially leading to earlier detection and better outcomes. The research is being conducted at the Weill Medical College of Cornell University, leveraging a team of experts in cancer genetics and precision medicine.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with a family history of breast cancer or those who have genetic variants associated with increased breast cancer risk.
Not a fit: Patients without a family history of breast cancer or those who do not carry relevant genetic variants may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective breast cancer screening methods for patients.
How similar studies have performed: Previous research has shown promise in using genetic information for cancer risk prediction, indicating that this approach could be effective.
Where this research is happening
NEW YORK, UNITED STATES
- WEILL MEDICAL COLL OF CORNELL UNIV — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SHIEH, YIWEY — WEILL MEDICAL COLL OF CORNELL UNIV
- Study coordinator: SHIEH, YIWEY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Breast Cancer, Cancers, neoplasm/cancer